| abstract |
Formula I having agonistic action on peroxisome proliferator-activated receptor subtype δ (PPARδ) Novel compounds, pharmaceutical compositions containing such compounds, methods for their preparation, and use in the manufacture of a medicament for the treatment or prevention of diseases that can be treated or prevented by activating PPARδ (the diseases are metabolic Syndrome, obesity, dyslipidemia, pathological glycemia, insulin resistance, senile dementia and tumor). Novel intermediates used in the preparation of the novel compounds and methods for their preparation. |